Category: Press Releases

MILAN, Italy, April 19, 2023 (GLOBE NEWSWIRE) — Edison Energia, an Edison Group company active in the sale of electric power and natural gas to households and businesses and value-added services to the retail market, reached 2 million contracts including residential, SME and industrial customers, thereby consolidating its third position in the national market in terms of volumes of electric power and its second position in terms of volumes of natural gas sold. The company’s goal, through its strategic development plan to 2030, is to double the number of contracts to 4 million between commodities, energy efficiency services and products (photovoltaic technology, heat pumps, boilers and climate), electric mobility solutions and insurance products for the protection of domestic systems.

At the event to present the plan and celebrate the milestone, Nicola Monti, CEO of the Edison Group, explained that the group has “a strategic plan with three main growth axes between now and 2030”: renewables, natural gas and the growth of all market activities. Monti continued: “We are very satisfied with the goals achieved by Edison Energia, a company that best expresses the corporate values of quality, innovation and competence at the service of the domestic and industrial sectors.” The group’s CEO added that, “Edison is an operator committed to the ecological transition of our country through the entire industrial chain from generation to the marketing of energy products and services to all market segments.”

The goal is to achieve 4 million contracts by 2030, mainly through organic development but also through non-organic growth opportunities, with the acquisition of large and small companies – as has already happened between 2018 and 2022 with Gas Natural, Attiva, Energia Etica and Gaxa – as well as through participation in auctions following the end of the protected market. According to the CEO of Edison Energia, Massimo Quaglini, “today more than ever people are looking for a relationship based on trust, reliability and soundness of the supplier. Our unique 140-year history of excellence in the sector qualifies us to be a partner capable of fully satisfying these needs of our customers: we accompany families and businesses in learning about and progressively adopting increasingly advanced solutions for a conscious and sustainable energy consumption for all”, all this in a context in which the energy crisis and the concerns triggered by the scarcity of raw materials “have profoundly changed the behaviour in the purchasing choices of families and businesses”.

For more information:
Press Office LaPresse – ufficio.stampa@lapresse.it

A video accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/2f3bf836-7bb1-4e19-8998-ffa8c1261fa8

GlobeNewswire Distribution ID 8811009

• Dr. Santiago Munné, a pioneer in preimplantation genetic diagnosis, presented the new test at the PGDIS Conference
• The novel laboratory test will not only detect genes inherited from parents, but will also reveal new mutations that could lead to ‘de novo’ diseases such as autism

PARIS, April 18, 2023 (GLOBE NEWSWIRE) — Dr. Santiago Munné, a pioneer in preimplantation genetic diagnosis, presented the first whole genome sequencing test in embryos before delegates at the 20th Conference of the Preimplantation Genetic Diagnosis International Society (PGDIS), held this week in Paris.

In his plenary address attended by over 300 experts, Dr. Munné, an internationally recognized trailblazer in reproductive genetics, presented validation data for GenomeScreen, the test developed by the research team he leads at the biotechnology firm GenEmbryomics.

“We have known since we started working with embryo diagnostics back in 1993 that embryo selection would be key to pregnancy, especially in older patients. Over the last 30 years, our work has been focused on improving genetic embryo selection, though the definitive diagnostic approach—the one that provides the most information and the best outcomes—will doubtless be this one: whole genome sequencing of the embryo using just a few cells obtained from a biopsy. This test will open doors that we never knew existed,” says Munné of the work done at GenEmbryomics.

To understand the genome is to know everything about an embryo before transfer
GenomeScreen is a revolutionary new whole genome sequencing test for IVF embryos that has been described as “the most complete genetic test in IVF” by authorities at the PGDIS forum.

The test provides highly precise information on the genome sequence of the embryo and the genetic parents, offering families key preimplantation insights on embryo health and reproductive prognosis that can inform their decisions. Furthermore, this information will be invaluable to individuals born from IVF, as it will provide input on nutrigenomics or guidance on which medicines are most genetically suited to the patient.

“When we first started our research on embryo sequencing, our goal was to create a powerful, comprehensive tool that could equip fertility physicians with exhaustive data for precision screening,” recalls Dr. Nick Murphy, founder of GenEmbryomics. “Now that we have this tool and use it with 99% reliability, we are aware that this diagnosis not only provides information, but also substantially enhances the success of reproductive medicine,” adds Murphy.

Embryo sequencing will increase IVF success rates

Professor Munné, whose career as a leader in reproductive genetics spans over 20 years, has made enormous contributions to embryo selection and IVF treatment. With this test, he and his team of researchers solidify the role of genetic testing within reproductive medicine, increasing treatment success.

“The findings presented at the conference are the validation data for a test that will change embryo selection as we know it,” according to Munné. “Preimplantation genetic analysis with whole genome sequencing is a giant step forward: among other things, it will tell us which embryo will implant successfully, because we will know beforehand which one is truly healthy—the one that is free of diseases inherited from the parents or de novo illnesses, such as autism,” he concludes.

About GenEmbryomics
Founded by Dr. Nick Murphy in 2019, GenEmbryomics is a cutting-edge biotech company specializing in the genomic analysis of embryos to determine the most viable candidates for IVF implantation. Their work will lead to higher success rates in IVF cycles, thanks to their proprietary algorithms offering more accurate and efficient embryo selection based on each embryo’s whole genome.

For more information
Dulce Iborra Candela
+34 647942875
dulce@laembajadora.es

GlobeNewswire Distribution ID 8810850

Zero-trust cybersecurity demand drives business and operational growth for leading critical infrastructure protection solution provider

Tokyo, Japan, April 18, 2023 (GLOBE NEWSWIRE) — OPSWAT, the global leader in Critical Infrastructure Protection (CIP) cybersecurity solutions, announces its continued business expansion and operational growth in Japan due to rising demand for zero-trust cybersecurity solutions that protect critical infrastructure. OPSWAT also appoints Atsushi Takamatsu as the new Country General Manager, Japan, with the objective of spearheading operational excellence and accelerating OPSWAT’s penetration of the OT security market in the region.

OPSWAT attributes this growth to its strategic alliance with Net One Partners K.K. in driving the company’s IT and OT cybersecurity market expansion across Japan. OPSWAT’s customer growth has reached 190% year-over-year due to the strong demand in the finance, utilities, energy, heavy industry, and manufacturing sectors, including many central government ministries and agencies. As a result, OPSWAT has doubled its headcount by adding technical engineers, sales specialists, and marketing resources.

Atsushi Takamatsu brings over 17 years of management experience in the cybersecurity industry to his new role. Prior to joining OPSWAT, Takamatsu was Managing Director of Absolute and NetMotion Software in Japan, Director of Japan for BlueCat Networks, and held senior sales management positions at Citrix Systems Japan. He is excited to lead OPSWAT Japan and contribute to protecting Japan’s critical infrastructure organizations from destructive malware and zero-day attacks.

“I am delighted to serve as Country General Manager for OPSWAT Japan, which has experienced tremendous growth over the past two years,” said Takamatsu. “I have seen a significant increase in adoption in both the public and private sectors, and working with key customers including major Japanese airlines and Japan’s nuclear industry is a testament to that. I strongly believe that 2023 will be an important milestone year that will accelerate the OPSWAT’s penetration of the OT security market in the region.”

OPSWAT will establish a CIP Lab in Tokyo in collaboration with Net One Partners K.K. to offer advanced cyber security solutions and useful training to Japanese customers and partners.

“We are very pleased with OPSWAT Japan’s significant growth in the Japanese market,” said Tenaka-san, President, CEO. “We also sincerely welcome their increased resources for future growth and business expansion. Net One Partners looks forward to further strengthening our strategic partnership with OPSWAT Japan and delivering better solutions to the market to meet the growing demand for cyber security solutions in Japan. ”

About OPSWAT  

OPSWAT is a global leader in IT, OT and ICS critical infrastructure cybersecurity solutions and Deep Content Disarm and Reconstruction (CDR), protecting the world’s mission-critical organizations from malware and zero-day attacks. To minimize the risk of compromise, OPSWAT Critical Infrastructure Protection solutions safeguard both public and private sector organizations with the latest technology, processes, and hardware scanning to secure the transfer of data, files, and device access across critical networks. More than 1,500 organizations worldwide spanning Financial Services, Defense, Manufacturing, Energy, Aerospace, and Transportation Systems trust OPSWAT to secure their files and devices; ensure compliance with industry and government-driven policies and regulations, and protect their reputation, finances, employees, and customers from cyber-driven disruption. For more information on OPSWAT, visit www.opswat.com.

Attachment

• OPSWAT Announces Rapid Business Growth and Operational Expansion in Japan with New Country General Manager Appointment

Kazuto Aoki   
OPSWAT Japan
kazuto.aoki@opswat.com

GlobeNewswire Distribution ID 8810820

April 18, 2023

Latest clinical data set of 200,000 patients from over 200 hospitals, includes pandemic data for a broader and dependable foundation for machine learning

Amsterdam, the Netherlands and Cambridge, MA, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a health technology provider, today announced an expansion of its initiative with the Institute for Medical Engineering and Science (IMES) at the Massachusetts Institute of Technology (MIT) to allow health care researchers access to a new critical care data set to help advance machine learning and artificial intelligence (AI) in healthcare. The updated eICU Collaborative Research Database (eICU-CRD) includes de-identified data of 200,000 critical care patients, including patients who were impacted by COVID-19. The broader and clinically dependable data set will support the development of solutions that improve patient care and clinical outcomes.

During the COVID-19 pandemic, eICU and critical care saw a dramatic increase of patients and unique challenges in the way that care was provided, prompting Philips and IMES to expand the original data set, first released in 2016. The new secure database includes de-identified and detailed clinical information such as vital signs, pharmacy and medication orders, laboratory results, diagnoses, and novel severity of illness scores. The dataset gives comprehensive insights on patient treatments, co-morbidities, readmissions, and clinical outcomes.

Researchers at Philips and the Laboratory of Computational Physiology within IMES will grant researchers around the world access to the data to help develop advanced algorithms and provide new insights on critical care. The Laboratory of Computational Physiology will continue to serve as the academic research hub for the initiative and will provide and maintain access, as well as help educate researchers on the database and offer a platform for collaboration. The database is available for medical research, to those who are credentialed, who take human subjects training, and who agree to a data use agreement.

“The database, which includes patient information from 2020 and 2021, now contains significant overlap with the Covid-19 pandemic, yielding valuable patient data for research,” said Leo Anthony Celi, principal research scientist and clinical research director at the Laboratory of Computational Physiology at IMES. “This updated database is a vital resource for education, including in many courses at institutions like Harvard, MIT and Stanford; and training, as well as low-resource institutions,” said Jesse D. Raffa, research scientist in the Lab for Computational Physiology at IMES.

The eICU-CRD is the only dataset containing detailed critical care data from over 200 hospitals across the U.S., representing many ‘real-world’ challenges for successful deployment of algorithms and models, which are often not readily apparent in single-center datasets. Unlike other organizations that do not share data or only share single source data sets, Philips shares its data with credentialled researchers to help advance AI for improving outcomes in human health. More than 3,000 users have used the original database with citations in over 660 published academic research papers, including in Nature, The New England Journal of Medicine and the Journal of the American Medical Association.

“This initiative demonstrates our commitment to advancing machine learning and AI efforts, by making eICU data available for global research initiatives,” said Shiv Gopalkrishnan, General Manager of EMR & Care Management at Philips. “This is how we can enhance patient care and improve clinical outcomes: liberating and connecting data across systems and applications with integrated devices, systems and informatics, which can inform research with patient insights that can help clinicians make the right decision at the right time for their patients.”

For further information, please contact:

Silvie Casanova
Philips North America
Tel.+1 781 879 0692
E-mail: silvie.casanova@philips.com

Anna Hogrebe
Philips Global Press Office
Tel.: +1 416 270 6757
E-mail: anna.hogrebe@philips.com

Mindy Blodgett
MIT IMES
Tel.+1 617 324 4019
E-mail: mblodget@mit.edu

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About IMES
The Institute for Medical Engineering and Science (IMES) at the Massachusetts Institute of Technology (MIT) is an inclusive community of students, administrative staff, research staff, and faculty who research, work, educate, and learn, at the convergence of engineering, science, and medicine to transform human health for all. More about IMES can be found at imes.mit.edu.

Attachment

• A researcher reviews patient data

GlobeNewswire Distribution ID 1000804364

JCDC will benefit from Fortinet’s in-depth cybersecurity expertise and industry-leading threat intelligence from FortiGuard Labs

SUNNYVALE, Calif., April 18, 2023 (GLOBE NEWSWIRE) —

Ken Xie, Founder, Chairman of the Board, and Chief Executive Officer at Fortinet
“Fortinet is honored to become a member of JCDC to build on our existing collaboration and trusted relationship with the U.S. government to help improve our nation’s cybersecurity. Fortinet has a long track record of supporting mission-critical public-private partnerships and we look forward to collaborating with JCDC and sharing our expertise in cybersecurity, our broad visibility into threat activity, and the actionable threat intelligence we generate. We applaud the work JCDC has accomplished to forge cross sector collaboration since their founding in 2021 and look forward to helping JCDC mature its capabilities and contribute to building the United States’ cyber resiliency.”

News Summary 
Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced it has become a member of the Joint Cyber Defense Collaborative (JCDC), furthering the company’s commitment to strengthening the United States’ security posture and cybersecurity resilience. The Cybersecurity and Infrastructure Security Agency (CISA) established JCDC in 2021 to bring together public and private entities with the goal to gather, analyze and share actionable information to more proactively protect and defend against cyber threats. These types of collaborative efforts help build systemic resilience by both coordinating incident response and by addressing vulnerabilities and other cyber risks before they are exploited.

Fortinet will work with JCDC to leverage the company’s more than 20 years of cybersecurity leadership and expertise, including actionable threat research from FortiGuard Labs, Fortinet’s elite threat intelligence and research organization established in 2005. FortiGuard Labs continuously monitors the worldwide attack surface using mature artificial intelligence (AI) and machine learning (ML) technology to neutralize events and issue actionable updates.

Fortinet will share this timely and actionable threat intelligence and cyber best practices with the JCDC community to prevent risks and mitigate the greatest cyber threats and vulnerabilities faced by the United States and its international partners. This collaboration further expands Fortinet’s long-standing commitment to cross-industry and cross-sector partnerships with organizations such as Interpol and the World Economic Forum’s Centre for Cybersecurity to help combat today’s most pressing cyber challenges and to disrupt cybercrime.

About Fortinet
Fortinet (NASDAQ: FTNT) is a driving force in the evolution of cybersecurity and the convergence of networking and security. Our mission is to secure people, devices, and data everywhere, and today we deliver cybersecurity everywhere you need it with the largest integrated portfolio of over 50 enterprise-grade products. Well over half a million customers trust Fortinet’s solutions, which are among the most deployed, most patented, and most validated in the industry. The Fortinet Training Institute, one of the largest and broadest training programs in the industry, is dedicated to making cybersecurity training and new career opportunities available to everyone. FortiGuard Labs, Fortinet’s elite threat intelligence and research organization, develops and utilizes leading-edge machine learning and AI technologies to provide customers with timely and consistently top-rated protection and actionable threat intelligence. Learn more at https://www.fortinet.com, the Fortinet Blog, and FortiGuard Labs.

About the Joint Cyber Defense Collaborative  
Pursuant to new authority from Congress, the Cybersecurity and Infrastructure Security Agency (CISA) established JCDC in August 2021 to transform traditional public-private partnerships into real-time private-public operational collaboration and shift the paradigm from reacting to threats and vulnerabilities to proactively planning and taking steps to mitigate them. JCDC combines the visibility, insight, and innovation of the private sector with the capabilities and authorities of the federal cyber ecosystem to collectively drive down cyber risk to the nation at scale. Learn more about JCDC at CISA.gov/JCDC.

FTNT-O

Copyright © 2023 Fortinet, Inc. All rights reserved. The symbols ® and denote respectively federally registered trademarks and common law trademarks of Fortinet, Inc., its subsidiaries and affiliates. Fortinet’s trademarks include, but are not limited to, the following: Fortinet, the Fortinet logo, FortiGate, FortiOS, FortiGuard, FortiCare, FortiAnalyzer, FortiManager, FortiASIC, FortiClient, FortiCloud, FortiMail, FortiSandbox, FortiADC, FortiAI, FortiAIOps, FortiAntenna, FortiAP, FortiAPCam, FortiAuthenticator, FortiCache, FortiCall, FortiCam, FortiCamera, FortiCarrier, FortiCASB, FortiCentral, FortiConnect, FortiController, FortiConverter, FortiCWP, FortiDB, FortiDDoS, FortiDeceptor, FortiDeploy, FortiDevSec, FortiEdge, FortiEDR, FortiExplorer, FortiExtender, FortiFirewall, FortiFone, FortiGSLB, FortiHypervisor, FortiInsight, FortiIsolator, FortiLAN, FortiLink, FortiMoM, FortiMonitor, FortiNAC, FortiNDR, FortiPenTest, FortiPhish, FortiPlanner, FortiPolicy, FortiPortal, FortiPresence, FortiProxy, FortiRecon, FortiRecorder, FortiSASE, FortiSDNConnector, FortiSIEM, FortiSMS, FortiSOAR, FortiSwitch, FortiTester, FortiToken, FortiTrust, FortiVoice, FortiWAN, FortiWeb, FortiWiFi, FortiWLC, FortiWLM and FortiXDR. Other trademarks belong to their respective owners. Fortinet has not independently verified statements or certifications herein attributed to third parties and Fortinet does not independently endorse such statements. Notwithstanding anything to the contrary herein, nothing herein constitutes a warranty, guarantee, contract, binding specification or other binding commitment by Fortinet or any indication of intent related to a binding commitment, and performance and other specification information herein may be unique to certain environments.

GlobeNewswire Distribution ID

April 18, 2023

• Healthcare leaders are heavily investing in AI or plan to do so for both critical decision support and operational efficiency, helping tackle staff shortages
• Largest global survey of its kind shows healthcare leaders continue to recognize virtual care as key to bringing care closer to patients, wherever they are

Amsterdam, the Netherlands, and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of its Future Health Index (FHI) 2023 report: Taking healthcare everywhere. Unveiled at HIMSS23, the eighth annual FHI 2023 global report shows healthcare leaders are increasingly prepared to invest in AI, recognize the opportunity virtual care offers to bring care closer to patients, and acknowledge the importance of building partnerships to improve care.

“Post Covid, demand for healthcare services has increased, but there are fewer healthcare professionals available to serve this growing number of patients. This year’s report shows healthcare leaders are prepared to invest in AI to alleviate this pressure on their workforce,” said Shez Partovi, Chief Innovation & Strategy Officer and Business Leader of Enterprise Informatics at Philips. “In order to genuinely relieve that burden, it’s essential that new AI capabilities are interoperable and embedded into clinical and operational workflows.”

Tackling staff shortages with digital innovation and automation
Planned investments in AI over the next three years show the biggest increase in critical decision support (39% in 2023, up from 24% in 2021). This was a top choice among cardiology (50%) and radiology (48%) leaders. The percentage of healthcare leaders planning to invest in AI for operational efficiency, including automating documentation, scheduling patients, and performing routine tasks, remained steady at 37%.

Bringing care closer to the patient, expanding access points and convenience
With moving care to new settings a key contributor to reducing staffing pressure, 70% of all respondents say virtual care has had the biggest impact on improving patient care or will in the next three years. The report also shows virtual care is moving into more areas of care, meeting patients where they are. 82% of healthcare leaders say that their facility currently provides intensive or critical care supported virtually (41%) or plans to in the next three years (41%). Virtual care also plays a vital role in attracting and retaining talent, with 44% of younger healthcare professionals indicating new care delivery models that connect different care settings are a top priority when choosing where to work.

Partnering across the healthcare ecosystem to expand the reach of care
One in three (34%) healthcare leaders are building partnerships outside their healthcare system to be able to provide the best possible care. Among their top choices of current partners are diagnostic imaging or screening centers (28%), ambulatory care centers (23%), emergency medical centers (23%), and retailers or pharmacies (22%) – all of which can also help in bringing care closer to the patient.

The FHI 2023 report is based on proprietary research among nearly 3,000 healthcare leaders and younger healthcare professionals conducted in 14 countries. To access the report, visit Future Health Index 2023.

For further information, please contact:

Meredith Amoroso
Philips Global Press Office
Tel.: +1 724-584-8991
E-mail: meredith.amoroso@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

• Philips 2023 FHI: Healthcare leaders focused on staff shortages
• Philips 2023 FHI: Healthcare leaders want to step up AI investments
• Download the 2023 Philips Future Health Index Global Report
• Philips FHI 2023 Global Findings: Infographic

GlobeNewswire Distribution ID 1000804559

IVECO GROUP N.V.

20230418_Inaugurazione IVECO BUS Foggia – da sin Gerrit Marx Adolfo Urso Domenico Nucera Michele Emiliano

Turin, 18^th April 2023. IVECO BUS, the urban, intercity and tourism bus brand of Iveco Group N.V. (MI: IVG), inaugurated today its new Foggia plant dedicated to the production of zero- and low-emission buses, in front of public authorities, trade union representatives, customers, suppliers and partners.

Adolfo Urso, Minister for Business and Made in Italy, and Michele Emiliano, President of the Puglia Region, attended the event. Gilberto Pichetto Fratin, Minister of the Environment and Energy Security, sent a video message.

According to the industrial plan, at full speed the new facility will employ 100 highly specialised people working lines equipped with the most advanced Industry 4.0 technologies. The production volume of the plant will be 1,000 vehicles per year: high-tech buses with zero-emission propulsion (battery electric and hydrogen electric) and low-emission propulsion (methane/biomethane, traditional fuels and biofuels).

The plant emits zero net CO₂ emissions. 100% of its energy comes from renewable sources, including over 1,000 photovoltaic panels that produce 640 MWh per year. The entire project focuses on reducing energy consumption and recycling, making use of high-performance construction materials, Intelligent LED lighting and rainwater reuse.

Iveco Group is already present in Foggia with its FPT Industrial plant for the production of industrial engines and 1,600 employees, which make this one the largest industrial establishments in Puglia. The investment in the new plant of approximately 40 million euros – that will be partially offset by funds from the PNRR, the National Recovery and Resilience Plan ‒ is strategic and puts two pillars of the PNRR into practice: “Green revolution and ecological transition” and “Infrastructure for sustainable mobility”.

The inauguration of the new plant comes just eight months after the first stone was laid and less than a year after IVECO BUS announced its intention to return to producing buses in Italy. Through this “Sustainable Enhancement of the Italian Bus Supply Chain” project, IVECO BUS is contributing to the energy and ecological transition process for public transport in Italy, ensuring as well as the acquisition of new technologies for the country. In addition to Foggia, the project involves other Iveco Group sites and Italian suppliers: the Research and Development activity related to zero-emission propulsions and battery production is being conducted at the Turin site of FPT Industrial ‒ the Group’s powertrain technology brand ‒ and the completion of the bus production that will take place in the new Foggia plant will utilise components (from seats to information technology systems) provided by the Italian supply chain.

Gerrit Marx, CEO, Iveco Group, said: “The new IVECO BUS plant in Foggia represents an important investment for Iveco Group, which is fully in line with our strategy to maintain and strengthen our presence in Italy at centres of excellence like our historic engine plant in Foggia. It is therefore with pride and pleasure that today we concretely mark the return of our bus production to Italy. In this way, we will provide the Italian public transport sector with our most technologically advanced and environmentally sustainable vehicles”.

Iveco Group N.V. (MI: IVG) is the home of unique people and brands that power your business and mission to advance a more sustainable society. The eight brands are each a major force in its specific business: IVECO, a pioneering commercial vehicles brand that designs, manufactures, and markets heavy, medium, and light-duty trucks; FPT Industrial, a global leader in a vast array of advanced powertrain technologies in the agriculture, construction, marine, power generation, and commercial vehicles sectors; IVECO BUS and HEULIEZ, mass-transit and premium bus and coach brands; IDV, for highly-specialised defence and civil protection equipment; ASTRA, a leader in large-scale heavy-duty quarry and construction vehicles; MAGIRUS, the industry-reputed firefighting vehicle and equipment manufacturer; and IVECO CAPITAL, the financing arm which supports them all. Iveco Group employs more than 35,000 people around the world and has 26 manufacturing plants and 29 R&D centres. Further information is available on the Company’s website www.ivecogroup.com

Media Contacts:
Francesco Polsinelli, Mob: +39 335 1776091
Fabio Lepore, Mob: +39 335 7469007
E-mail: mediarelations@ivecogroup.com

Attachments

• 20230418_PR_Iveco_Group_new_plant_Foggia
• IVECO GROUP N.V.

GlobeNewswire Distribution ID 1000804608

Former Dell EMC, Zerto, and Semperis Sales Leader to Drive Go-To-Market Initiatives Through Company’s Next Phase of Growth

Boston, Massachusetts, April 18, 2023 (GLOBE NEWSWIRE) — HYCU, Inc., the world’s fastest-growing multi-cloud data protection as a service company, today announced that Coley Burke joined to lead the global sales organization and drive go-to-market programs to accommodate scale and growth for continued worldwide expansion. Burke joins HYCU on the heels of the recent introduction of R-Cloud, the world’s first developer-led data protection platform to address the underserved needs of SaaS application users for enterprise-class data protection, and after the company closed 2022 with more than 3,600 customers and a Series B funding round that brings the total raised to date to $140M. Burke will report to HYCU Founder and CEO Simon Taylor.

“The ongoing fight against ransomware and the ever-increasing need for data protection regardless of platform or application in use, has never been greater,” said Coley Burke. “HYCU is at a pivotal moment in time, solving the challenges that legacy backup solutions cannot address while changing the game for companies and partners that need cloud-native, cost-effective and efficient SaaS backup where few solutions exist today. I am excited to join HYCU to drive and lead sales through the company’s next phase of hypergrowth.”

As Chief Revenue Officer, Burke will be responsible for driving HYCU’s global go-to-market strategy and accelerating growth and scale to accommodate customer and partner interest. Burke brings more than 30 year’s experience as a results-driven executive to lead sales and business development efforts. Prior to HYCU, Burke was CRO at Semperis where he increased demand for identity driven cyber resilience to offset the growing rise of cybersecurity risks to enterprises globally. Before Semperis, Burke was CRO at Zerto, successfully leading go-to-market for the global IT resilience company prior to the acquisition by HPE. Burke has held sales and go-to-market positions at EMC, Kashya, IBM, Quantum, and Arrow Electronics and has extensive background in software, data protection, infrastructure, storage, and BCDR products and solutions. Throughout his career, Burke has led successful market strategy and revenue growth for many of the industry’s leading product portfolios.

“We are thrilled that Coley is joining HYCU and excited that he will be instrumental in driving HYCU’s go-to-market and sales efforts around the world to handle the growing interest in our multi-cloud and SaaS data protection solutions,” said Simon Taylor, Founder and CEO, HYCU Inc. “Coley is an impressive sales leader with deep roots in data protection, and a power of positivity wherever he has worked. His outlook and attitude is infectious and our growing customer base and teams will enjoy every minute he has to spend with them. Welcome Coley, I am looking forward to working together with you, and the rest of the executive team to share why HYCU is quickly becoming the data protection provider of choice, regardless of data location and platform in use.”

To learn more about HYCU’s multi-cloud and SaaS backup and recovery as a service solutions, visit tryhycu.com.

About HYCU
HYCU is the fastest-growing leader in the multi-cloud and SaaS data protection as a service industry. By bringing true SaaS-based data backup and recovery to on-premises, cloud-native, and SaaS environments, the company provides unparalleled data protection, migration, disaster recovery, and ransomware protection to thousands of companies worldwide. As an award-winning and recognized visionary in the industry, HYCU solutions eliminate complexity, risk, and the high cost of legacy-based solutions, providing data protection simplicity to make the world safer. With an industry-leading NPS score of 91, customers experience frictionless, cost-effective data protection, anywhere, everywhere. HYCU has raised $140M in VC funding to date and is based in Boston, Mass. Learn more at www.hycu.com.

Attachment

• Coley Burke Joins HYCU as First CRO

Don Jennings
HYCU, Inc.
617-791-1710
don.jennings@hycu.com

Katie Helander
The Bulleit Group
hycu@bulleitgroup.com

GlobeNewswire Distribution ID 8809935

ZUG, Switzerland, April 18, 2023 (GLOBE NEWSWIRE) — The Aleph Zero Foundation, the non-profit entity overseeing the development of Aleph Zero, a public, permissionless, and leaderless blockchain boasting ink! WebAssembly (WASM) smart contracts and Liminal (privacy-enhancing ZK-SNARKs and MPC technology), announced today the launch of the $50 million Aleph Zero Ecosystem Funding Program. The program consists of grants, incubation, and acceleration across all stages of product development, and is dedicated to supporting developer teams to build on Aleph Zero. Interested parties can apply at alephzero.org/EFP.

The grant recipients will receive up to $500,000 per project in grant funding, and gain exclusive access to Aleph Zero’s venture capital pool. Aleph Zero’s partner, Kudelski Security, will also provide free or heavily-subsidized security design consultations and code audits, while Amazon Web Services will provide infrastructure credits to selected teams and projects via its Activate program. Core developer of Aleph Zero, Cardinal Cryptography, will assist with research and development as well as token economy design. In addition, the Aleph Zero partner network will provide marketing, branding, UX, product design, and operational support as needed.

“The Aleph Zero Foundation is thrilled to announce the launch of the Ecosystem Funding Program, a monumental step forward towards empowering projects to build on Aleph Zero. Project ideas can range from proof-of-concept and other early-stage companies to experienced teams with solutions deployed on different platforms,” said Magdalena Oleksy, Ecosystem Lead. “The Foundation is particularly interested in supporting teams that are focused on use cases in DeFi and broader economic empowerment, but we’re open to assisting ambitious teams from all verticals. Applications showcasing Aleph Zero’s unique features and focused on compliant privacy solutions are of particular interest. The Foundation is also eager to support various network improvements and tooling for the WASM ink! ecosystem.”

With the recent release of ink! 4.0 smart contracts on Aleph Zero Mainnet, Aleph Zero is ready to house new dApps. With around 30 different products already in development, Aleph Zero Foundation is keen to provide more resources to its developer community. To date, a number of projects are being built under the Ecosystem Funding Program’s pilot program, such as:

• Abax: A decentralized lending and borrowing protocol boasting an innovative position risk model;
• ArtZero: An NFT marketplace built on Aleph Zero that grants users quick and easy access to digital collectibles;
• AZERO Domains: A leading domain name service on Aleph Zero;
• DRKVRS: A unique, dark metaverse experience designed by world-renowned writers and producers.
• Gatenox: An enterprise-grade decentralized identity platform that allows exchanges, applications, Web 3.0 services, as well as fintechs and banks to integrate a seamless, near-zero cost, instant Know-Your-Customer (KYC), Anti-Money Laundering (AML), and Customer Due Diligence (CDD) processes. Gatenox raised $2.5m in their seed funding round.
• Interlock: A decentralized security platform that delivers Web3-centered solutions to combat cybercrime by allowing users to share anonymized data regarding online threats and rewards them through Interlock’s native token. Interlock is currently closing its seed funding round.
• Syncra: A no-code solution for creating privacy-enhanced DAOs using Aleph Zero and Liminal.
• Metamask Snap: A dedicated Snap to onboard users to the Aleph Zero network.

“Our experience in Aleph Zero’s Ecosystem Funding Program has been invaluable. The grant and guidance have enabled us to code and audit our smart contracts with ease, which set us up for a successful token and product launch,” said Andrew Ciaccia, Co-founder and CMO of Interlock. “The consulting and feedback we received have been immensely helpful in refining our DeFi security products.”

“We’re excited to support the Ecosystem Funding Program and have already made contributions to a number of Aleph Zero projects”, says Maciej Skrzypczak, partner at Block54 Capital and advisor to the Aleph Zero team. “With prior experience in building and exiting companies, as well as working with a number of enterprise customers, we’re looking to support developers holistically—beyond simply providing funding.”

In addition to the Aleph Zero Foundation, the Ecosystem Funding Program is also backed by other long-term contributors to the project, such as Skynet Trading, NxGen, Diamond Atlas Capital, BlackDragon, Necker Ventures, Block54 Capital, Hodl.nl and Hodl Ventures, Pragma Ventures, RR2 Capital, Cardinal Cryptography and Cardinal Ventures, Bellwether Rocks, Offbeat Ventures, 727 Ventures, and others, as well as Aleph Zero core developers and a number of angel investors.

Participating VCs and angel investors will have the opportunity to engage with teams individually, and make future independent decisions with ecosystem projects. The Aleph Zero Foundation and its partner network aim to fund and empower innovations from developer teams that expand the capabilities, functionalities, and adoption of the Aleph Zero blockchain.

About Aleph Zero Foundation

The Aleph Zero Foundation oversees the research and development of the Aleph Zero blockchain, promotes its use, and funds ambitious teams seeking to bring innovative projects to the Aleph Zero community.

About Aleph Zero

Aleph Zero is a public, permissionless, and leaderless layer 1 blockchain built for use cases focused on optimal security, speed, and scalability. Aleph Zero can also support a variety of privacy-enhanced use cases through its Liminal technology. The goal of the platform is to enable builders from all verticals to benefit from a fundamentally improved distributed ledger design.

For media inquiries,
Ana Lezama
ana@serotonin.co

GlobeNewswire Distribution ID 8809734